Evaluating Safety and Immune Response to the HIV-1 CH505 Transmitted/Founder gp120 Adjuvanted With GLA-SE in Healthy, HIV-exposed Uninfected Infants
Clinical trial NCT04607408 · COMPLETED
Trial details
- NCT number
- NCT04607408
- Sponsor
- HIV Vaccine Trials Network
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-10
- Primary completion
- 2024-07-24
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.